Primary Health Properties Toekomstige groei

Future criteriumcontroles 3/6

De omzet van Primary Health Properties zal naar verwachting dalen met 0.4% per jaar, terwijl de jaarlijkse winst naar verwachting zal groeien met 40.4% per jaar. De winst per aandeel zal naar verwachting groeien met 41.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 8.2% zijn.

Belangrijke informatie

40.4%

Groei van de winst

41.1%

Groei van de winst per aandeel

Health Care REITs winstgroei	0%
Inkomstengroei	-0.4%
Toekomstig rendement op eigen vermogen	8.2%
Dekking van analisten	Good
Laatst bijgewerkt	25 Nov 2024

Recente toekomstige groei-updates

Geen updates

Recent updates

Winst- en omzetgroeiprognoses

DB:PP51 - Toekomstschattingen van analisten en financiële gegevens uit het verleden (GBP Millions )
Datum	Inkomsten	Inkomsten	Vrije kasstroom	Geldmiddelen uit operationele activiteiten	Gem. Aantal analisten
12/31/2026	164	167	N/A	150	5
12/31/2025	159	156	-26	145	7
12/31/2024	155	70	-2	141	7
6/30/2024	178	-9	135	135	N/A
3/31/2024	174	9	134	134	N/A
12/31/2023	170	27	134	134	N/A
9/30/2023	166	8	134	134	N/A
6/30/2023	161	-11	134	134	N/A
3/31/2023	158	23	126	126	N/A
12/31/2022	154	56	118	118	N/A
9/30/2022	152	116	122	122	N/A
6/30/2022	151	176	126	126	N/A
3/31/2022	148	158	133	133	N/A
12/31/2021	146	140	140	140	N/A
9/30/2021	144	142	132	132	N/A
6/30/2021	143	144	124	124	N/A
3/31/2021	141	128	122	122	N/A
12/31/2020	139	112	119	119	N/A
9/30/2020	136	93	112	112	N/A
6/30/2020	133	75	106	106	N/A
3/31/2020	127	2	100	100	N/A
12/31/2019	121	-71	94	94	N/A
9/30/2019	109	-71	88	88	N/A
6/30/2019	97	-71	82	82	N/A
3/31/2019	88	2	75	75	N/A
12/31/2018	80	74	69	69	N/A
9/30/2018	78	80	66	66	N/A
6/30/2018	76	86	64	64	N/A
3/31/2018	74	89	N/A	62	N/A
12/31/2017	73	92	N/A	60	N/A
9/30/2017	71	77	N/A	60	N/A
6/30/2017	70	63	N/A	60	N/A
3/31/2017	69	53	N/A	59	N/A
12/31/2016	67	44	N/A	57	N/A
9/30/2016	66	46	N/A	56	N/A
6/30/2016	65	49	N/A	55	N/A
3/31/2016	64	53	N/A	56	N/A
12/31/2015	63	56	N/A	57	N/A
9/30/2015	62	52	N/A	56	N/A
6/30/2015	61	47	N/A	54	N/A
3/31/2015	61	42	N/A	51	N/A
12/31/2014	60	37	N/A	49	N/A
9/30/2014	56	33	N/A	47	N/A
6/30/2014	52	29	N/A	46	N/A
3/31/2014	47	24	N/A	41	N/A
12/31/2013	42	20	N/A	37	N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: Er wordt voorspeld dat PP51 de komende 3 jaar winstgevend zal worden, wat wordt beschouwd als een snellere groei dan de spaarquote ( 1% ).

Winst versus markt: Er wordt verwacht dat PP51 de komende 3 jaar winstgevend zal worden. Dit wordt gezien als een groei die boven het gemiddelde van de markt ligt.

Hoge groeiwinsten: Er wordt verwacht dat PP51 binnen 3 jaar winstgevend zal worden.

Omzet versus markt: De omzet van PP51 zal naar verwachting de komende 3 jaar dalen ( -0.4% per jaar).

Hoge groei-inkomsten: De omzet van PP51 zal naar verwachting de komende 3 jaar dalen ( -0.4% per jaar).

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: Het rendement op eigen vermogen PP51 zal naar verwachting over 3 jaar laag zijn ( 8.2 %).

Primary Health Properties Toekomstige groei

Future criteriumcontroles 3/6

Belangrijke informatie

Recente toekomstige groei-updates

Recent updates

Dividend of UK£0.017 announced

Primary Health Properties Plc Announces Fourth Quarterly Interim Dividend in 2024, Payable on 22 November 2024

Now 20% undervalued

Now 24% undervalued

First half 2024 earnings released: EPS: UK£0.003 (vs UK£0.03 in 1H 2023)

Fourth quarter dividend of UK£0.017 announced

Primary Health Properties Plc Announces Third Quarterly Interim Dividend in 2024, Payable on 16 August 2024

Primary Health Properties Plc to Report First Half, 2024 Results on Jul 24, 2024

Now 21% undervalued

Now 21% undervalued

Now 22% undervalued after recent price drop

Primary Health Properties plc Elects Mark Davies as Director

Now 21% undervalued after recent price drop

Now 20% undervalued after recent price drop

Fourth quarter dividend of UK£0.017 announced

Primary Health Properties plc Announces Second Quarterly Interim Dividend, Payable on May 17, 2024

CFO & Director recently bought €276k worth of stock

Full year 2023 earnings released: EPS: UK£0.02 (vs UK£0.042 in FY 2022)

Primary Health Properties Plc Appoints Bandhana (Bina) Rawal as an Independent Non-Executive Director

Primary Health Properties Plc to Report Q4, 2023 Results on Feb 28, 2024

Primary Health Properties plc Announces Resignation of Steven Owen as Chairman

Primary Health Properties Plc Announces Fourth Quarterly Interim Dividend, Payable on 24 November 2023

Primary Health Properties Plc agreed to acquire Enhanced Community Care ("ECC") facility at Ballincollig, Ireland for €29.64 million.

Primary Health Properties Plc, Annual General Meeting, Apr 24, 2024

Now 23% undervalued after recent price drop

First half 2023 earnings released: EPS: UK£0.03 (vs UK£0.08 in 1H 2022)

New minor risk - Share price stability

Primary Health Properties Plc Announces Third Quarterly Interim Dividend, Payable on 18 August 2023

Investor sentiment deteriorates as stock falls 15%

Primary Health Properties Plc to Report First Half, 2023 Results on Jul 26, 2023

Now 22% undervalued after recent price drop

Full year 2022 earnings released: EPS: UK£0.042 (vs UK£0.10 in FY 2021)

Primary Health Properties PLC acquired Axis Technical Services Limited.

Primary Health Properties PLC to Report Fiscal Year 2022 Results on Feb 22, 2023

Primary Health Properties plc Announces First Quarterly Interim Dividend for 2023, Payable on 23 February 2023

Primary Health Properties PLC Announces CEO Changes

Primary Health Properties plc Announces Fourth Quarterly Interim Dividend for 2022, Payable on November 25, 2022

Investor sentiment deteriorated over the past week

First half 2022 earnings released

Primary Health Properties PLC (LSE:PHP) acquired Strawberry Hill Medical Centre in Newbury for £7.25 million.

An unknown buyer exchanged contracts to acquire 13 Medical Centres of Primary Health Properties PLC for £27.7 million.

Primary Health Properties plc Announces Third Quarterly Interim Dividend for 2022, Payable on August 19, 2022

Insufficient new directors

Primary Health Properties PLC (LSE:PHP) acquired Chiswick Medical Centre for £34.5 million.

Primary Health Properties PLC (LSE:PHP) acquired a Clinical Facility in Chertsey for £6.95 million.

Insufficient new directors

CFO & Director recently bought €111k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Primary Health Properties PLC Announces the Launch of Net Zero Carbon Framework

Primary Health Properties PLC (LSE:PHP) agreed to acquire Medical and office facility in the North East of England for £10 million.

Primary Health Properties PLC (LSE:PHP) acquired Parkside Medical Centre in Boston, Lincolnshire for £6.8 million.

Primary Health Properties PLC (LSE:PHP) acquired Townside Primary Care Centre and adjacent office building in Bury, Lancashire for £40 million.

First half 2021 earnings released: EPS UK£0.054 (vs UK£0.032 in 1H 2020)

Primary Health Properties PLC (LSE:PHP) acquired modern purpose-built primary care centre in Shankill, Dublin for €3.8 million.

CFO & Director recently bought €61k worth of stock

Full year 2020 earnings released: EPS UK£0.088 (vs UK£0.065 loss in FY 2019)

Revenue beats expectations

New 90-day high: €1.74

Primary Health Properties PLC to Report Fiscal Year 2020 Results on Feb 18, 2021

New 90-day high: €1.71

Primary Health Properties plc Appoints Paul Wright as Company Secretary

Primary Health Properties PLC (LSE:PHP) acquired Primary Care Centre in Enniscorthy for €12.6 million.

Primary Health Properties PLC (LSE:PHP) acquired West Derby Medical Centre for £4.6 million.

Primary Health Properties PLC (LSE:PHP) entered into a conditional share purchase agreement to acquire Nexus Tradeco Holdings Limited from Harry Hyman for £32.5 million.

New 90-day low: €1.53

New 90-day low: €1.57

New 90-day low: €1.59

Primary Health Properties PLC (LSE:PHP) acquired 22 medical centres across England and Wales for £54 million.

Primary Health Properties PLC has completed a Follow-on Equity Offering in the amount of £140.00475 million.

Winst- en omzetgroeiprognoses

Toekomstige groeivoorspellingen analisten

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Ontdek groeibedrijven